Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of BIOVICA INTERNATIONAL
No Price
Closing Price XSTO 30.04.2026:
0,35 SEK
30.04.2026 10:25
Current Prices from BIOVICA INTERNATIONAL
Exchange
Ticker
Currency
Last Trade
Price
Daily Change
NASDAQ STOCKHOLM AB
BIOVIC-B.ST
SEK
30.04.2026 10:25
0,35 SEK
-
Share Float & Liquidity
Free Float95,98 %
Shares Float177,72 M
Shares Outstanding185,17 M
Company Profile for BIOVICA INTERNATIONAL Share
Biovica International AB (publ), a biotechnology company, develops and commercializes blood-based biomarker assays that enhance the monitoring and predicting of cancer therapies in Sweden and internationally. It primarily focuses on breast cancer. The company develops DiviTum, a biomarker assay that measures the activity of the enzyme thymidine kinase-1 in blood serum or cell cultures. It serves cancer institutes, pharmaceutical companies, and collaborative groups. The company was incorporated in 2008 and is headquartered in Uppsala, Sweden.
